Kyle Crane was the protagonist of Dying Light, but some time has passed and he’s changed a lot, so we see him from a different perspective.
It’s been almost ten years since Dying Light was released, and it had a profound impact on open-world zombie games, adding a parkour movement system to the hack-and-slash gameplay of Techland’s previous game, Dead Island, and creating a fresh and exciting experience. Dying Light 2: Stay Human has since been released, and now Dying Light: The Beast (which will be free for those who purchase the more expensive version of DL2), announced on the opening night of Gamescom, could bring another twist to the franchise.
This game will not require Dying Light 2 and will offer around 20 hours of gameplay. It will star Kyle Crane, the protagonist of the first episode. Until now, we didn’t know what happened to him since then, as he was last seen in the 2016 DLC Dying Light: The Following. Crane’s mission was to find a cure for the Harran virus in a remote quarantine zone. While there, he encountered a mysterious cult that claimed to have found it. He met the cult’s leader, the Mother, but it turned out that he had been tricked: to her, the cure meant that it would turn people into human-volatile hybrid monsters.
So would Crane, and he had two choices. As Crane, we could kill the mother, or we could side with her. In the latter case, Crane destroys Harran with nukes, and in the former, Crane returns to Harran before turning into a Volatile, so to speak. But we don’t know which ending is considered credible. Well, Dying Light 2: Stay Human takes place 22 years after the first episode, and it’s not clear what happened to Crane (some have mentioned a tragic fate, but nothing more has emerged). Dying Light: The Beast essentially confirms that Harran was not bombed, as Crane is not fully functioning as a human…
Dying Light: The Beast takes place 13 years after the first episode and 9 years before the second. This will make it interesting to see how the two games tie together.
Source: GameRant
Leave a Reply